Table 2 Detection of HML-10(DAP3) pol transcripts by previously reported microarray studies [79]

Normal tissue and non-tumor cell lines (n = 23)

Cervix [22], epidermal keratinocytes (HaCaT) [26], thyroid [22], umbilical vein endothelial cells (HUVEC) [40], uterus [22] (5/23)

Blood [22, 23], breast [25], colon [22], heart [22], liver [22], lung [22], mamma [22, 23], neural stem cells (HNSC.100) [40], ovary [22], placenta [22], prostate [22], rectum [22], skeletal muscle [22], stomach [22], testes [22] (15/23)

Brain [22, 24], kidney [22, 27], skin [22, 41] (3/23)

Primary tumors and tumor cell lines (n = 13)

CAKI (renal carcinoma) [26], GliNS1 (neural tumor stem line) [40], HEK293 (embryonic kidney) [26], HeLa (cervix adenocarcinoma) [26], HuH-7 (hepatocellular carcinoma) [26], MIA PaCa-2 (pancreatic carcinoma) [26], SK-N-MC (neuroblastoma) [42, 43], SK-N-SH (neuroblastoma) [42], T47D (ductal breast epithelial carcinoma) [26], U-251MG (glioblastoma) [42] (10/13)

Breast cancer [25], U-138MG (glioblastoma) [42] (2/13)

Renal cell carcinoma [27] (1/13)